HOSPITAL READMISSIONS AMONG PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION TREATED WITH THE NEW ORAL ANTICOAGULANTS, APIXABAN, DABIGATRAN, AND RIVAROXABAN Article

Full Text via DOI: 10.1016/S0735-1097(16)30806-3 Web of Science: 000375188701649
Industry Collaboration

Cited authors

  • Deitelzweig, Steven; Gupta, Kiran; Nadkarni, Anagha; Trocio, Jeffrey; Lin, Jay; Lingohr-Smith, Melissa

Publication date

  • 2016

International Standard Serial Number (ISSN)

  • 0735-1097

Start page

  • 805

End page

  • 805

Volume

  • 67

Issue

  • 13